Compositions and methods for the therapy and diagnosis of...

Details Compositions and methods for the therapy and diagnosis of... Compositions and methods for the therapy and diagnosis of...

2007-10-30

2010-12-21

Helms, Larry R. (Department: 1642)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

C424S184100

Reexamination Certificate

active

07855271

ABSTRACT:
Compositions and methods for the therapy and diagnosis of cancer, particularly breast cancer, are disclosed. Illustrative compositions comprise one or more breast tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of diseases, particularly breast cancer.

REFERENCES:
patent: 4962187 (1990-10-01), Pant
patent: 5215926 (1993-06-01), Etchells, III et al.
patent: 5240856 (1993-08-01), Goffe et al.
patent: 5478556 (1995-12-01), Elliott et al.
patent: 5668267 (1997-09-01), Watson et al.
patent: 5843435 (1998-12-01), Slavin
patent: 5855889 (1999-01-01), Watson et al.
patent: 5861381 (1999-01-01), Chambon et al.
patent: 5891857 (1999-04-01), Holt et al.
patent: 5922836 (1999-07-01), Watson et al.
patent: 5968754 (1999-10-01), Watson et al.
patent: 5981731 (1999-11-01), Monia
patent: 5986170 (1999-11-01), Subjeck
patent: 6004756 (1999-12-01), Watson et al.
patent: 6150168 (2000-11-01), Woo et al.
patent: 6153386 (2000-11-01), Lalouel et al.
patent: 6387697 (2002-05-01), Yuqiu et al.
patent: 6518237 (2003-02-01), Yuqiu et al.
patent: 6528054 (2003-03-01), Jiang et al.
patent: 6573368 (2003-06-01), Yuqiu et al.
patent: 6579973 (2003-06-01), Yuqiu et al.
patent: 6586572 (2003-07-01), Jiang et al.
patent: 6590076 (2003-07-01), Yuqiu et al.
patent: 6680197 (2004-01-01), Jiang et al.
patent: 6756477 (2004-06-01), Jiang et al.
patent: 6844325 (2005-01-01), Jiang et al.
patent: 6958361 (2005-10-01), Houghton et al.
patent: 6969518 (2005-11-01), Houghton et al.
patent: 2002/0009738 (2002-01-01), Houghton et al.
patent: 2002/0150581 (2002-10-01), Jiang et al.
patent: 2003/0170631 (2003-09-01), Houghton et al.
patent: 2226901 (1998-07-01), None
patent: 2226910 (1998-10-01), None
patent: 2284642 (1998-10-01), None
patent: WO 89/06280 (1989-07-01), None
patent: WO 91/16116 (1991-10-01), None
patent: WO 91/16629 (1991-10-01), None
patent: WO 92/07243 (1992-04-01), None
patent: WO 96/29430 (1996-09-01), None
patent: WO 97/02280 (1997-01-01), None
patent: WO 97/22349 (1997-06-01), None
patent: WO 97/25426 (1997-07-01), None
patent: WO 97/25431 (1997-07-01), None
patent: WO 98/04742 (1998-02-01), None
patent: WO 98/21331 (1998-05-01), None
patent: WO 98/24928 (1998-06-01), None
patent: WO 98/33915 (1998-08-01), None
patent: WO 98/45328 (1998-10-01), None
patent: WO 98/54963 (1998-12-01), None
patent: WO 99/09155 (1999-02-01), None
patent: WO 99/14230 (1999-03-01), None
patent: WO 00/08210 (2000-02-01), None
patent: WO 00/37643 (2000-06-01), None
patent: WO 00/43420 (2000-07-01), None
patent: WO 00/60076 (2000-10-01), None
patent: WO 00/73801 (2000-12-01), None
patent: WO 01/37779 (2001-05-01), None
patent: WO 01/47959 (2001-07-01), None
patent: WO 01/51628 (2001-07-01), None
patent: WO 01/57270 (2001-08-01), None
patent: WO 01/75171 (2001-10-01), None
patent: WO 01/79286 (2001-10-01), None
patent: WO 02/059377 (2002-08-01), None
patent: WO 02/083956 (2002-10-01), None
MPSRCH search result, 2009, us-11.930.080.475.rup. Result 4, pp. 1-2.
MPSRCH search result, 2009, us-11.930.080.475.oligo.rai. Result 40, p. 1.
MPSRCH search result, 2009, us-11.930.080.474.n2poligo.rai. Result 40, pp. 1-2.
Bowie (Science, 1990, 257:1306-1310).
Burgess et al ( J of Cell Bio. 111:2129-2138, 1990).
Lazar et al (Molecular and Cellular Biology, 1988, 8:1247-1252).
Kirkin et al, APMIS, 1998, 106: 665-679.
Holmes (Exp. Opin.Invest. Drugs, 2001, 10(3):511-519).
Roitt et al, 1998, (Immunology, 4th ed, Mosby, London, p. 7.7-7.8).
Roger, I et al, 1988, Bioscience Reports, 8(4): 359-368.
Banki et al, 1994, JBC, 269 (4): 2847-51.
Bost et al, 1988, Immunol Investigation, 17 (6&7): 577-586).
Alberts et al. Mol. Biol. Cell, 3rd ed., p. 455, 1994.
Anderson and Seilhamer, “A comparison of selected MRNA and protein abundances in human liver”,Electrophoresis18: 533-537, 1997.
Anderson, W.F., “Human gene therapy,”Nature392(Suppl):25-30, Apr. 30, 1998.
Bodey, B. et al., “Failure of Cancer Vaccines: The Significant Limitation of the Approach to Immunotherapy,”Anticancer Research20:2665-2676, 2000.
Boon, T., “Toward a Genetic Analysis of Tumor Rejection Antigens”,Adv. Cancer Res. 58: 177-210, 1992.
Bork, P., “Powers and Pitfalls in Sequence Analysis: The 70% Hurdle”,Genome Research10(4): 398-400, Apr. 2000.
Burmer, G.C. et al., “Frequency and Spectrum of c-Ki-rasMutations in Human Sporadic Colon Carcinoma, Carcinomas Arising in Ulcerative Colitis, and Pancreatic Adenocarcinoma,”Environmental Health Perspectives93:27-31, 1991.
Buskens, C. et al., “Adenocarcinomas of the Gastro-Esophageal Junction: A Comparative Study of the Gastric Cardia and the Esophagus with Respect to Cyclooxygenase-2 Expression,”Digestive Disease Week Abstracts and Itinerary Planner, Abstract No. 850, 2003.
Cameron, E.R., “Recent Advances in Transgenic Technology,”Molecular Biotechnology7: 253-265, 1997.
Chang and Shu, “Current status of adoptive immunotherapy of cancer,”Critical Reviews in Oncology/Hematology22(3):213-228, Apr. 1996.
Cheever and Chen, “Therapy with cultured T cells: principles revisited,”Immunological Reviews, 157: 177-194, 1997.
Cheever et al., “Potential uses of interleukin 2 in cancer therapy,”Immunobiol. 172:365-382, 1986.
Cheli et al.,Clin Chem. 44(4): 765-72, 1998.
Chen et al., “T-cells for tumor therapy can be obtained from antigen-loaded sponge implants,”Cancer Research54(4):1065-1070, Feb. 15, 1994.
Cole et al., “Characterization of the functional specificity of a cloned T-cell receptor heterodimer recognizing the MART-1 melanoma antigent,”Cancer Research, 55:748-752, Feb. 15, 1995.
Conner et al., “Trk receptor alterations in Alzheimer's disease,”Mol Brain Res. 42: 1-17, 1996.
Curti, B.D., “Physical barriers to drug delivery in tumors”,Critical Reviews in Oncology/Hematology14: 29-39, 1993.
Dermer.,Bio/Technol. 12: 320, 1994.
Doerks, T. et al., “Protein annotation: detective work for function prediction”,Trends in Genetics14(6): 248-250, Jun. 1998.
Durrant L., “Cancer vaccines,”Anti-Cancer Drugs8:727-733, 1997.
Eshhar Z., “Tumor-specific T-bodies: toward clinical application,”Cancer Immunol Immnother45:131-136, 1997.
Ezzell, C., “Cancer ‘Vaccines’: An Idea Whose Time Has Come?”The Journal of NIH Research7: 46-49, Jan. 1995.
Freshney, Cult. Animal Cells, A Manual of Basic Technique, Alan R. Lisc. Inc. p. 4, 1983.
Fu et al., “Translational regulation of human p53 gene expression,”EMBO J. 15: 4392-4401, 1996.
Gardner, R.L. et al., “Reflections on the biology of embryonic stem (ES) cells,”Int. J. Dev. Biol. 41: 235-243, 1997.
Gaubin et al., J Immunol. 1999, 162(5): 2631-8.
GenBank Accession No. AA398925, Apr. 25, 1997.
GenBank Accession No. AA864891, Feb. 20, 1998.
GenBank Accession No. AI9511189. (First appeared in GenBank-NCBI on Aug. 19, 1999).
GenBank Accession No. B15703. (First appeared in GenBank-NCBI on Jun. 4, 1998).
GenBank Accession No. B17512. (First appeared in GenBank-NCBI on Jun. 4, 1998).
GenBank Accession No. X88318. (First appeared in GenBank-NCBI on Jul. 19, 1996).
GenBank Accession No. XP—035844. (First appeared in GenBank-NCBI on Jul. 16, 2001).
GenBank Accession No. AAK27325, Mar. 28, 2001.
GenBank Accession No. AC036170, Apr. 9, 2000.
GenBank Accession No. AC069200, May 24, 2000.
GenBank Accession No. AF269087, Mar. 28, 2001.
GenBank Accession No. AI687645, May 27, 1999.
GenBank Accession No. AL157387, Feb. 18, 2000.
GenBank Accession No. AL359312, Dec. 7, 2001.
GenBank Accession No. AQ280806, Nov. 22, 1998.
GenBank Database, Accession No. AA219147, Feb. 7, 1997.
GenBank Database, Accession No. AI272025, Nov. 17, 1998.
GenBank Database, Accession N

Affiliated with

Also associated with

Rating

Compositions and methods for the therapy and diagnosis of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods for the therapy and diagnosis of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for the therapy and diagnosis of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4199390